Liu, L., Chenfeng, T., Wang, J., Xiang, Z., Zeng, Y., Wei, X. (2026). Becotatug vedotin plus pucotenlimab as first-line therapy in patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6130